419
Views
7
CrossRef citations to date
0
Altmetric
Original Articles

Examining Factors Associated with Non-Fatal Overdose among People Who Inject Drugs in Rural Appalachia

, &

References

  • Ahmad, F. B., Rossen, L. M., Spencer, M. R., Warner, M., Sutton, P. (2018). Provisional drug overdose death counts. National Center for Health Statistics. https://www.cdc.gov/nchs/nvss/vsrr/drug-overdose-data.htm.
  • Allen, S. T., O’Rourke, A., White, R. H., Schneider, K. E., Kilkenny, M., & Sherman, S. G. (2019). Estimating the numbers of people who inject drugs in a rural county in Appalachia. American Journal of Public Health, 109(3), 445–450. http://doi.org/10.2105/AJPH.2018.304873)
  • Beatty, K., Hale, N., Meit, M., Heffernan, M., Dougherty, M., Rocha, L., Ruane, K., Pack, R., Mathis, S., Brooks, B., Hagaman, A. Pettyjohn, S. (2019). Creating a culture of health in appalachia: Disparities and bright spots. Retrieved March, 2020, from https://www.arc.gov/assets/research_reports/HealthDisparitiesRelatedtoOpioidMisuseinAppalachiaApr2019.pdf
  • Behar, E., Bagnulo, R., & Coffin, P. O. (2018). Acceptability and feasibility of naloxone prescribing in primary care settings: A systematic review. Preventive Medicine, 114, 79–87. https://doi.org/10.1016/j.ypmed.2018.06.005
  • Bohnert, A. S., Roeder, K., & Ilgen, M. A. (2010). Unintentional overdose and suicide among substance users: A review of overlap and risk factors. Drug and Alcohol Dependence, 110(3), 183–192. https://doi.org/10.1016/j.drugalcdep.2010.03.010
  • Brady, J. E., Giglio, R., Keyes, K. M., DiMaggio, C., & Li, G. (2017). Risk markers for fatal and non-fatal prescription drug overdose: A meta-analysis. Injury Epidemiology, 4(1), 24–24. https://doi.org/10.1186/s40621-017-0118-7
  • Brinkley-Rubinstein, L., Macmadu, A., Marshall, B. D. L., Heise, A., Ranapurwala, S. I., Rich, J. D., & Green, T. C. (2018). Risk of fentanyl-involved overdose among those with past year incarceration: Findings from a recent outbreak in 2014 and 2015. Drug and Alcohol Dependence, 185, 189–191. https://doi.org/10.1016/j.drugalcdep.2017.12.014
  • Britton, P. C., Wines, J. D., Jr., & Conner, K. R. (2010). Non-fatal overdose in the 12 months following treatment for substance use disorders. Drug and Alcohol Dependence, 107(1), 51–55. https://doi.org/10.1016/j.drugalcdep.2009.09.005
  • Carrà, G., Crocamo, C., Borrelli, P., Tabacchi, T., Bartoli, F., Popa, I., Montomoli, C., & Clerici, M. (2017). Area-level deprivation and adverse consequences in people with substance use disorders: Findings from the Psychiatric and Addictive Dual Disorder in Italy (PADDI) study. Substance Use & Misuse, 52(4), 451–458. https://doi.org/10.1080/10826084.2016.1240696
  • Caudarella, A., Dong, H., Milloy, M. J., Kerr, T., Wood, E., & Hayashi, K. (2016). Non-fatal overdose as a risk factor for subsequent fatal overdose among people who inject drugs. Drug and Alcohol Dependence, 162, 51–55. https://doi.org/10.1016/j.drugalcdep.2016.02.024
  • Centers for Disease Control and Prevention (2017). Annual Surveillance Report of Drug-Related Risks and Outcomes—United States, 2017. MMWR Surveill Summ 2017. Retrieved September 13, 2019, from https://www.cdc.gov/drugoverdose/data
  • Centers for Disease Control and Prevention. (2016). Prescription opioid overdose data. 2016. April 23, 2017. Retrieved Accessed July 2019, from https://www.cdc.gov/drugoverdose/data/overdose.html
  • Centers for Disease Control and Prevention. (2019). CDC guideline for prescribing opioids for chronic pain. Retrieved Accessed July 2019, from https://www.cdc.gov/drugoverdose/pdf/guidelines_at-a-glance-a.pdf
  • Clark, A. K., Wilder, C. M., & Winstanley, E. L. (2014). A systematic review of community opioid overdose prevention and naloxone distribution programs. Journal of Addiction Medicine, 8(3), 153–163. https://doi.org/10.1097/adm.0000000000000034
  • Coffin, P. O., Tracy, M., Bucciarelli, A., Ompad, D., Vlahov, D., & Galea, S. (2007). Identifying injection drug users at risk of nonfatal overdose. Academic Emergency Medicine: official Journal of the Society for Academic Emergency Medicine, 14(7), 616–623. https://doi.org/10.1197/j.aem.2007.04.005
  • Compton, W. M., Jones, C. M., & Baldwin, G. T. (2016). Relationship between nonmedical prescription-opioid use and heroin use. The New England Journal of Medicine, 374(2), 154–163. https://doi.org/10.1056/NEJMra1508490
  • Darke, S., Ross, J., Williamson, A., & Teesson, M. (2005). The impact of borderline personality disorder on 12-month outcomes for the treatment of heroin dependence. Addiction (Abingdon, England), 100(8), 1121–1130. https://doi.org/10.1111/j.1360-0443.2005.01123.x
  • Dasgupta, N., Beletsky, L., & Ciccarone, D. (2018). Opioid crisis: No easy fix to its social and economic determinants. American Journal of Public Health, 108(2), 182–186. https://doi.org/10.2105/AJPH.2017.304187
  • Davidson, P. J., McLean, R. L., Kral, A. H., Gleghorn, A. A., Edlin, B. R., & Moss, A. R. (2003). Fatal heroin-related overdose in San Francisco, 1997–2000: A case for targeted intervention. Journal of Urban Health: bulletin of the New York Academy of Medicine, 80(2), 261–273. https://doi.org/10.1093/jurban/jtg029
  • Devries, J., Rafie, S., & Polston, G. (2017). Implementing an overdose education and naloxone distribution program in a health system. Journal of the American Pharmacists Association: Japha, 57(2S), S154–s160. https://doi.org/10.1016/j.japh.2017.01.002
  • Dowell, D., Noonan, R. K., & Houry, D. (2017). Underlying factors in drug overdose deaths. JAMA, 318(23), 2295–2296. https://doi.org/10.1001/jama.2017.15971
  • Dunn, M. S., Goodrow, B., Givens, C., & Austin, S. (2008). Substance use behavior and suicide indicators among rural middle school students. The Journal of School Health, 78(1), 26–31. https://doi.org/10.1111/j.1746-1561.2007.00262.x
  • Dunn, K. M., Saunders, K. W., Rutter, C. M., Banta-Green, C. J., Merrill, J. O., Sullivan, M. D., Weisner, C. M., Silverberg, M. J., Campbell, C. I., Psaty, B. M., & Von Korff, M. (2010). Opioid prescriptions for chronic pain and overdose: A cohort study. Annals of Internal Medicine, 152(2), 85–92. https://doi.org/10.7326/0003-4819-152-2-201001190-00006
  • Elzey, M. J., Barden, S. M., & Edwards, E. S. (2016). Patient characteristics and outcomes in unintentional, non-fatal prescription opioid overdoses: A systematic review. Pain Physician, 19(4), 215–228.
  • Federation of State Medical Boards. (2017). Guidelines for the chronic use of opioid analgesics. Retrieved from July, 2019, from https://www.fsmb.org/siteassets/advocacy/policies/opioid_guidelines_as_adopted_april-2017_final.pdf
  • Fendrich, M., Becker, J., & Hernandez-Meier, J. (2019). Psychiatric symptoms and recent overdose among people who use heroin or other opioids: Results from a secondary analysis of an intervention study. Addictive Behaviors Reports, 10, 100212. https://doi.org/10.1016/j.abrep.2019.100212
  • Follman, S., Arora, V. M., Lyttle, C., Moore, P. Q., & Pho, M. T. (2019). Naloxone prescriptions among commercially insured individuals at high risk of opioid overdose. JAMA Network Open, 2(5), e193209–e193209. https://doi.org/10.1001/jamanetworkopen.2019.3209
  • Galea, S., Ahern, J., Vlahov, D., Coffin, P. O., Fuller, C., Leon, A. C., & Tardiff, K. (2003). Income distribution and risk of fatal drug overdose in New York City neighborhoods. Drug and Alcohol Dependence, 70(2), 139–148. https://doi.org/10.1016/S0376-8716(02)00342-3
  • Galea, S., Nandi, A., Coffin, P. O., Tracy, M., Markham Piper, T., Ompad, D., & Vlahov, D. (2006). Heroin and cocaine dependence and the risk of accidental non-fatal drug overdose. Journal of Addictive Diseases, 25(3), 79–87. https://doi.org/10.1300/J069v25n03_10
  • Global Appraisal of Individual Needs. (2013). Global appraisal of individual needs—Short screener (GAIN-SS): Administration and Scoring Manual. Administration and Scoring Manual Version 3. https://chestnut.app.box.com/v/GAIN-SS-Materials/file/63780162801.
  • Green, T. C., Grau, L. E., Blinnikova, K. N., Torban, M., Krupitsky, E., Ilyuk, R., Kozlov, A., & Heimer, R. (2009). Social and structural aspects of the overdose risk environment in St. Petersburg, Russia. The International Journal on Drug Policy, 20(3), 270–276. https://doi.org/10.1016/j.drugpo.2008.07.002
  • Greene, M. S., & Chambers, R. A. (2015). Pseudoaddiction: Fact or fiction? An investigation of the medical literature. Current Addiction Reports, 2(4), 310–317. https://doi.org/10.1007/s40429-015-0074-7
  • Hall, A. J., Logan, J. E., Toblin, R. L., Kaplan, J. A., Kraner, J. C., Bixler, D., Crosby, A. E., & Paulozzi, L. J. (2008). Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA, 300(22), 2613–2620. https://doi.org/10.1001/jama.2008.802
  • Heckathorn, D. D. (1997). Respondent-driven sampling: A new approach to the study of hidden populations*. Social Problems, 44(2), 174–199. https://doi.org/10.2307/3096941
  • Hedegaard, H., Chen, L. H., & Warner, M. (2015). Drug-poisoning deaths involving heroin: United States, 2000–2013 (NCHS Data Brief 190). 1–8. US Department of Health and Human Services. https://www.cdc.gov/nchs/data/databriefs/db190.pdf
  • Hedegaard, H., Miniño, A. M., Warner, M. (2018). Drug overdose deaths in the United States, 1999–2017 (NCHS Data Brief, no 329). National Center for Health Statistics. Retrieved November 24, 2019, from https://www.cdc.gov/nchs/data/databriefs/db329-h.pdf
  • Hedegaard, H., Warner, M., & Minino, A. M. (2017). Drug overdose deaths in the United States, 1999–2016 (NCHS Data Brief, 294), 1–8. United States Department of Health and Human Services. https://www.cdc.gov/nchs/data/databriefs/db294.pdf
  • Jarman, M. P., Castillo, R. C., Carlini, A. R., Kodadek, L. M., & Haider, A. H. (2016). Rural risk: Geographic disparities in trauma mortality. Surgery, 160(6), 1551–1559. https://doi.org/10.1016/j.surg.2016.06.020
  • Joudrey, P. J., Khan, M. R., Wang, E. A., Scheidell, J. D., Edelman, E. J., McInnes, D. K., & Fox, A. D. (2019). A conceptual model for understanding post-release opioid-related overdose risk. Addiction Science & Clinical Practice, 14(1), 17–17. https://doi.org/10.1186/s13722-019-0145-5
  • Kentucky Health News. (2019). Anti-overdose drug naloxone (narcan) isn’t getting enough at-risk and rural people, including many counties in Kentucky. Retrieved March 14, 2020, from ci.uky.edu/kentuckyhealthnews/2019/08/09/
  • Kentucky Office of Drug Control Policy. (2018). Overdose fatality report. Retrieved March 14, 2020, from https://odcp.ky.gov/Reports/2018%20Kentucky%20Overdose%20Fatality%20Report.pdf
  • Keyes, K. M., Cerdá, M., Brady, J. E., Havens, J. R., & Galea, S. (2014). Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. American Journal of Public Health, 104(2), e52–e59. https://doi.org/10.2105/AJPH.2013.301709
  • Kim, D., Irwin, K. S., & Khoshnood, K. (2009). Expanded access to naloxone: Options for critical response to the epidemic of opioid overdose mortality. American Journal of Public Health, 99(3), 402–407. https://doi.org/10.2105/AJPH.2008.136937
  • Lake, S., Hayashi, K., Buxton, J., Milloy, M.-J., Dong, H., Wood, E., Montaner, J., & Kerr, T. (2015). The effect of prescription opioid injection on the risk of non-fatal overdose among people who inject drugs. Drug and Alcohol Dependence, 156, 297–303. https://doi.org/10.1016/j.drugalcdep.2015.09.026
  • Latkin, C. A., Hua, W., & Tobin, K. (2004). Social network correlates of self-reported non-fatal overdose. Drug and Alcohol Dependence, 73(1), 61–67. https://doi.org/10.1016/j.drugalcdep.2003.09.005
  • Liebling, E. J., Green, T. C., Hadland, S. E., & Marshall, B. D. L. (2018). Injection drug use and overdose among young adults who use prescription opioids non-medically. Addictive Behaviors, 76, 20–26. https://doi.org/10.1016/j.addbeh.2017.07.017
  • Lipari, R. N., Van Horn, S. L. (2017). Trends in substance use disorders among adults aged 18 or older. The CBHSQ Report: June 29, 2017. Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration. https://www.samhsa.gov/data/sites/default/files/report_2790/ShortReport-2790.html
  • Lyons, R. M., Yule, A. M., Schiff, D., Bagley, S. M., & Wilens, T. E. (2019). Risk factors for drug overdose in young people: A systematic review of the literature. Journal of Child and Adolescent Psychopharmacology, 29(7), 487–497. https://doi.org/10.1089/cap.2019.0013
  • Mack, K. A., Jones, C. M., & Ballesteros, M. F. (2017). Illicit drug use, illicit drug use disorders, and drug overdose deaths in metropolitan and nonmetropolitan areas-United States. American Journal of Transplantation, 17(12), 3241–3252. https://doi.org/10.1111/ajt.14555
  • Man, L. H., Best, D., Gossop, M., Stillwell, G., & Strang, J. (2004). Relationship between prescribing and risk of opiate overdose among drug users in and out of maintenance treatment. European Addiction Research, 10(1), 35–40. https://doi.org/10.1159/000073724
  • Manemann, S. M., Chamberlain, A. M., Roger, V. L., Griffin, J. M., Boyd, C. M., Cudjoe, T. K. M., … Finney Rutten, L. J. (2018). Perceived social isolation and outcomes in patients with heart failure. Journal of the American Heart Association, 7(11). https://doi.org/10.1161/jaha.117.008069
  • McLean, K. (2016). “There's nothing here”: Deindustrialization as risk environment for overdose. The International Journal on Drug Policy, 29, 19–26. https://doi.org/10.1016/j.drugpo.2016.01.009
  • Milloy, M. J. S., Kerr, T., Mathias, R., Zhang, R., Montaner, J. S., Tyndall, M., & Wood, E. (2008). Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility. The American Journal of Drug and Alcohol Abuse, 34(4), 499–509. https://doi.org/10.1080/00952990802122457
  • Mills, K. L., Teesson, M., Ross, J., Darke, S., & Shanahan, M. (2005). The costs and outcomes of treatment for opioid dependence associated with posttraumatic stress disorder. Psychiatric Services (Washington, D.C.), 56(8), 940–945. https://doi.org/10.1176/appi.ps.56.8.940
  • Moody, L., Satterwhite, E., & Bickel, W. K. (2017). Substance use in rural central appalachia: Current status and treatment considerations. Rural Mental Health, 41(2), 123–135. https://doi.org/10.1037/rmh0000064
  • Moy, E., Garcia, M. C., Bastian, B., Rossen, L. M., Ingram, D. D., Faul, M., Massetti, G. M., Thomas, C. C., Hong, Y., Yoon, P. W., & Iademarco, M. F. (2017). Leading causes of death in nonmetropolitan and metropolitan areas—United States, 1999–2014. MMWR. Surveillance Summaries, 66(1), 1–8. DOI: https://doi.org/10.15585/mmwr.ss6601a1
  • National Institute on Drug Abuse. (2017). Opioid-involved overdose deaths. Retrieved March 14, 2020, from https://www.drugabuse.gov/opioid-summaries-by-state/kentucky-opioid-summary
  • National Institute on Drug Abuse. (2018). What is heroin and how is it used? Retrieved February 22, 2019; March, 2020, from: https://www.drugabuse.gov/publications/research-reports/heroin/what-heroin
  • National Institute on Drug Abuse. (2019). Overdose Death Rates. Retrieved July 2019, from https://www.drugabuse.gov/related-topics/trends-statistics/overdose-death-rates
  • National Organization of State Offices of Rural Health. (2017). Lessons learned from rural opioid overdose reversal grant recipients. Retrieved March 2020, from https://nosorh.org/wp-content/uploads/2017/05/ROOR-Report-1.pdf
  • O’Driscoll, P. T., McGough, J., Hagan, H., Thiede, H., Critchlow, C., & Alexander, E. R. (2001). Predictors of accidental fatal drug overdose among a cohort of injection drug users. American Journal of Public Health, 91(6), 984–987. https://doi.org/10.2105/ajph.91.6.984
  • Park, J. N., Weir, B. W., Allen, S. T., Chaulk, P., & Sherman, S. G. (2018). Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduction Journal, 15(1), 34. https://doi.org/10.1186/s12954-018-0240-z
  • Paulozzi, L. J., & Xi, Y. (2008). Recent changes in drug poisoning mortality in the United States by urban-rural status and by drug type. Pharmacoepidemiol Drug Saf, 17(10), 997–1005. https://doi.org/10.1002/pds.1626
  • Peters, P. J., Pontones, P., Hoover, K. W., Patel, M. R., Galang, R. R., Shields, J., Blosser, S. J., Spiller, M. W., Combs, B., Switzer, W. M., Conrad, C., Gentry, J., Khudyakov, Y., Waterhouse, D., Owen, S. M., Chapman, E., Roseberry, J. C., McCants, V., Weidle, P. J., … Duwve, J. M. (2016). HIV infection linked to injection use of oxymorphone in Indiana, 2014–2015. New England Journal of Medicine, 375(3), 229–239. https://doi.org/10.1056/NEJMoa1515195
  • Rosenblum, A., Parrino, M., Schnoll, S. H., Fong, C., Maxwell, C., Cleland, C. M., Magura, S., & Haddox, J. D. (2007). Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence, 90(1), 64–71. https://doi.org/10.1016/j.drugalcdep.2007.02.012
  • Schmitz, D., Meit, M., Rose, R., Crawford, P., Putnam, T., McNally, B. (2016). Rural communities in crisis: Strategies to address the opioid crisis. National Rural Health Association Policy Brief. Retrieved from September 13, 2019, from https://www.ruralhealthweb.org/getattachment/Advocate/Policy-Documents/RuralCommunitiesinCrisisStrategiestoAddresstheOpioidCrisisPolicyPaperApril2016.pdf.aspx.
  • Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths—United States, 2013–2017. Morbidity and Mortality Weekly Report, 67(51–52), 1419–1427.
  • Seth, P., Scholl, L., Rudd, R. A., & Bacon, S. (2018). Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. MMWR. Morbidity and Mortality Weekly Report, 67(12), 349–358. https://doi.org/10.15585/mmwr.mm6712a1
  • Sherman, S. G., Cheng, Y., & Kral, A. H. (2007). Prevalence and correlates of opiate overdose among young injection drug users in a large U.S. city. Drug and Alcohol Dependence, 88(2–3), 182–187. https://doi.org/10.1016/j.drugalcdep.2006.10.006
  • Shiels, M. S., Berrington de González, A., Best, A. F., Chen, Y., Chernyavskiy, P., Hartge, P., Khan, S. Q., Pérez-Stable, E. J., Rodriquez, E. J., Spillane, S., Thomas, D. A., Withrow, D., & Freedman, N. D. (2019). Premature mortality from all causes and drug poisonings in the USA according to socioeconomic status and rurality: An analysis of death certificate data by county from 2000–15. The Lancet. Public Health, 4(2), e97–e106. https://doi.org/10.1016/S2468-2667(18)30208-1
  • Stoove, M. A., Dietze, P. M., & Jolley, D. (2009). Overdose deaths following previous non-fatal heroin overdose: Record linkage of ambulance attendance and death registry data. Drug and Alcohol Review, 28(4), 347–352. https://doi.org/10.1111/j.1465-3362.2009.00057.x
  • Substance Abuse and Mental Health Services Administration. (2014). Results from the 2013 National Survey on Drug Use and Health. 2014 (NSDUG Series H-48. HHS Publication No. (SMA) 14–4863). Retrieved July 2019, from https://www.samhsa.gov/data/sites/default/files/NSDUHresultsPDFWHTML2013/Web/NSDUHresults2013.pdf
  • Tobin, K. E., & Latkin, C. A. (2003). The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. Journal of Urban Health: bulletin of the New York Academy of Medicine, 80(2), 220–229. https://doi.org/10.1093/jurban/jtg025
  • Turner, B. J., & Liang, Y. (2015). Drug overdose in a retrospective cohort with non-cancer pain treated with opioids, antidepressants, and/or sedative-hypnotics: Interactions with mental health disorders. Journal of General Internal Medicine, 30(8), 1081–1096. https://doi.org/10.1007/s11606-015-3199-4
  • Vadivelu, N., Kai, A. M., Kodumudi, V., Zhu, R., & Hines, R. (2017). Pain management of patients with substance abuse in the ambulatory setting. Current Pain and Headache Reports, 21(2), 9. https://doi.org/10.1007/s11916-017-0610-3
  • Velander, J. R. (2018). Suboxone: Rationale, science, misconceptions. The Ochsner Journal, 18(1), 23–29.
  • Wilder, C. M., Miller, S. C., Tiffany, E., Winhusen, T., Winstanley, E. L., & Stein, M. D. (2016). Risk factors for opioid overdose and awareness of overdose risk among veterans prescribed chronic opioids for addiction or pain. Journal of Addictive Diseases, 35(1), 42–51. https://doi.org/10.1080/10550887.2016.1107264
  • Zoorob, M. J., & Salemi, J. L. (2017). Bowling alone, dying together: The role of social capital in mitigating the drug overdose epidemic in the United States. Drug and Alcohol Dependence, 173, 1–9. https://doi.org/10.1016/j.drugalcdep.2016.12.011

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.